Related Experiment Videos
Yohimbine augmentation of fluvoxamine in refractory depression: a single-blind study
A Cappiello1, C J McDougle, R T Malison
1Abraham Ribicoff Research Facilities, Connecticut Mental Health Center, New Haven, CT 06519, USA.
Biological Psychiatry
|December 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Superior mesenteric artery-related outcomes in fenestrated/branched endografting for complex aortic aneurysms.
Frontiers in cardiovascular medicine·2023
Attachment styles, identification of feelings and psychiatric symptoms in functional neurological disorders.
Journal of psychosomatic research·2021
A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder.
Journal of autism and developmental disorders·2019
Communication Deficits and the Motor System: Exploring Patterns of Associations in Autism Spectrum Disorder (ASD).
Journal of autism and developmental disorders·2016
Is particle beam an up-to-date LC-MS interface? State of the art and perspectives.
Mass spectrometry reviews·2016
Cannabis Use and Age-Related Acceleration of Psychosis Onset: A Meta-Analysis.
Biological psychiatry·2026
Polycation chain length determines the in vivo mRNA delivery efficiency of block copolymer micelles.
Biomaterials science·2026
Driving Drugs Deeper: Force-Driven Microneedle Systems for Active Therapy and Their Road Towards Clinical Implementation.
Small (Weinheim an der Bergstrasse, Germany)·2026
Mumio Potentiates Temozolomide by Inducing Apoptosis and Ferroptosis in Glioblastoma Cells.
Current pharmaceutical design·2026
Current Targeted Nanoparticle Therapy for Alzheimer's Disease: Current Advances and Future Prospects.
Current neurovascular research·2026
Clinical Presentation, Diagnosis, Treatment, and Outcome of Heart Disease in Becker Muscular Dystrophy.
Anatolian journal of cardiology·2026
Clinical Pharmacology of Eplontersen, the First Approved GalNAc-Conjugated Antisense Oligonucleotide.
Journal of clinical pharmacology·2026